• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    AeroClean Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8/23/23 5:20:10 PM ET
    $AERC
    Environmental Services
    Utilities
    Get the next $AERC alert in real time by email
    0001872356 false 0001872356 2023-08-23 2023-08-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 23, 2023 (August 23, 2023)

     

    Molekule Group, Inc.
    (Exact name of registrant as specified in its charter)

     

    Delaware   001-41096   45-3213164
    (State or other jurisdiction
     of incorporation)
      (Commission 
    File Number)
      (IRS Employer
    Identification No.)

     

    10455 Riverside Dr.
    Palm Beach Gardens, FL
      33410
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (833) 652-5326

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading 
    Symbol(s)
      Name of each exchange on which registered
    Common stock, par value $0.01 per share   MKUL   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

     

    Item 8.01. Other Events.

     

    Molekule Group, Inc. (the “Company” or “Molekule”) is filing this Current Report on Form 8-K to update certain items previously reported in its Quarterly Report on Form 10-Q for the period ended June 30, 2023.

     

    Balance Sheet and Liquidity

     

    As previously reported, for the six months ended June 30, 2023, the Company incurred a net loss of $34.9 million and its net cash used in operating activities was $28.0 million. In addition, at June 30, 2023, the Company’s accumulated deficit was $42.8 million and we had approximately $5.3 million of cash. Notwithstanding the development of Molekule 360 hub (our indoor air quality management solution), integration of software and device technologies and satisfactory performance in our direct to consumer and retail revenues, revenues from our B2B channel have performed below the Company’s expectations and, as a result, the Company is reducing its cost base. Backlog and orders for our new indoor air quality solutions from enterprise and commercial customers have fallen below expectations, resulting in efforts to defer or reduce costs while the Company continues to build a market and demand for its indoor air quality B2B business.

     

    Based on the current liquidity position of the Company and delays in its IoT cloud deployment independence and orders from the B2B business, our board of directors and management have been exploring, and are continuing to explore, various capital raising opportunities, including but not limited to a rights offering or private placement of securities. Some or all of the net proceeds from any capital raise would be used to invest in cost reduction programs associated with our products and services, conducting research and development and funding operations.

     

    The Company is currently in discussions with its principal lender, Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (“SVB”), to restructure its indebtedness. As of June 30, 2023, we had $4.3 million outstanding under a senior term loan with SVB, accruing interest at 9.25%, and maturing in March 2028, and $30 million outstanding under a mezzanine loan with SVB, accruing interest at 14.25%, and maturing in March 2028. In addition, the Company’s subsidiary has a legacy building lease in a building which the Company no longer occupies, that since May 2023, payments for rent thereunder have been obtained by the landlord from the subsidiary’s previously posted cash letter of credit. That letter of credit will be depleted by approximately mid-September 2023. The Company, its subsidiary, and the landlord are in ongoing discussions concerning the termination of that legacy lease.

     

    The Company has accrued liabilities for the reasons discussed above and will need to obtain funds in the third quarter of 2023 in order to fund operations through the third quarter of 2023. Such funds would also afford the Company time to explore and take advantage of growth opportunities and identify potential strategic partnerships. There can be no assurance that the Company will obtain funds, that the Company’s subsidiary will reach a mutually acceptable termination agreement with its landlord on the legacy building lease, that the Company will reach an agreement with SVB, on acceptable terms and conditions, or that any cost-cutting measures of the Company will be sufficient to continue operations. If the Company cannot achieve any of the foregoing, the Company will not be able to continue as a going concern and will need to explore restructuring and reorganization initiatives.

     

    Merger Agreement with Aura

     

    On February 26, 2023, we entered into a merger agreement with Aura Smart Air Ltd. (“Aura”), a company organized under the laws of the State of Israel (the “Merger Agreement”).

     

    As previously disclosed, on August 14, 2023, we informed Aura that we were terminating the Merger Agreement, in accordance with Section 8.02 and Section 8.01(c)(i) of the Merger Agreement. We believe that Aura has committed a material and incurable breach of Section 6.02 of the Merger Agreement such that we are entitled to terminate the Merger Agreement pursuant to Section 8.01(c)(i)(B) of the Merger Agreement. On August 14, 2023, Aura notified us that it disputed the termination of the Merger Agreement and believes that we have breached Section 6.09 of the Merger Agreement. We are highly confident that we are not in breach of the Merger Agreement.

     

    Notwithstanding Molekule’s termination of the Merger Agreement for, among other things, Aura’s failure to operate its business in the ordinary course, we had intended to continue discussions with Aura regarding future sales, marketing and technology collaboration and had intended to continue discussions regarding the parties’ current arrangements in connection with, and certain disagreements under, the surviving stand-alone Technology Collaboration Agreement and Co-Distribution Agreement entered into contemporaneously with the Merger Agreement. However, on August 22, 2023, Aura publicly reported that it had received notice from its supplier that provides IoT connectivity services to Aura’s products that such supplier had unilaterally disconnected all Aura products from the supplier’s cloud services, so that the data from the sensors installed in Aura’s products are no longer being transferred to Aura and, as a result, cannot be displayed on Aura’s platform and application used by Aura’s end customers, as part of the product’s characteristics, and Aura has no possibility to control the characteristics of the various remote products. As a result, the Aura devices that Molekule sold and previously offered to sell through the Co-Distribution Agreement will no longer transmit data to or from Aura supplier’s cloud and thus will not have IoT functionality, including control and monitoring. Molekule’s legacy products do not depend on Aura’s supplier’s services and thus will not be impacted by such supplier’s suspension of Aura’s product IoT connectivity capabilities. The Company does not believe this will have a material adverse effect on its business. The Company continues to evaluate the impact of this development on its business.

     

     

     

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current beliefs and expectations of our management and are subject to known and unknown risks and uncertainties. Words or expressions such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “may,” “will,” “projects,” “could,” “should,” “would,” “seek,” “forecast” or other similar expressions help identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in the forward-looking statements as a result of various factors. Although Molekule believes that the expectations reflected in the forward-looking statements are reasonable based on information currently available, Molekule cannot assure you that the expectations will prove to have been correct. Accordingly, you should not place undue reliance on these forward-looking statements. In any event, these statements speak only as of the date of this Current Report on Form 8-K. The parties undertake no obligation to revise or update any of the forward-looking statements to reflect events or circumstances after the date of this Current Report on Form 8-K or to reflect new information or the occurrence of unanticipated events.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    See the Exhibit Index below, which is incorporated by reference herein.

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      MOLEKULE GROUP, INC.
       
    Dated: August 23, 2023 By: /s/ Ryan Tyler
        Name: Ryan Tyler
        Title: Chief Financial Officer

     

     

     

    Get the next $AERC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AERC

    DatePrice TargetRatingAnalyst
    6/14/2022Buy → Hold
    The Benchmark Company
    2/1/2022Speculative Buy
    Benchmark
    More analyst ratings

    $AERC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AeroClean Technologies and Molekule Announce the Close of All-Stock Merger

      Establishes an industry-leading provider of premium, FDA-cleared air purification products and solutionsPositions the combined company to selectively pursue additional value-creating M&A opportunities within the broader indoor air quality ("IAQ") and cleantech industriesPowerful brand value and large installed base of over 350,000 air purification units creates an opportunity to drive recurring revenues through consumables and the launch of a software solution to monitor and control air quality on an enterprise-wide basisRecent developments include the release of Molekule's PECO-HEPA Tri-Power Filter for Air Pro, Air Mini+ and Air Mini; AeroClean's Pūrgo™ air purifier receiving FDA clearance

      1/12/23 9:00:00 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean's Pūrgo™ Air Purifier Receives FDA Clearance for the Elimination of SARS-CoV-2

      Additional Testing Being Performed to Confirm Elimination of Influenza and RSV PALM BEACH GARDENS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today announced that, the U.S. Food and Drug Administration ("FDA") has granted AeroClean 510k clearance (K223328) to update its Pūrgo™ air purifier's ("Pūrgo™") indications for use to include the elimination of SARS-CoV-2, the RNA virus that causes COVID-19. The FDA has reviewed the laboratory performance data and confirmed the applicability of Pūrgo to remove SARS-CoV-2 from the air in indoor environments. The clearance adds SARS-CoV-2 to th

      12/7/22 8:36:24 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Reports Third Quarter 2022 Financial Results

      PALM BEACH GARDENS, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today reported financial results for the three and nine months ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Highlights and Recent Developments The Company entered into a definitive agreement with Molekule, Inc. ("Molekule"), a market leader for premium air purifiers, to combine in an all-stock merger that the Company believes will establish a combined company as a market leader for premium, FDA-cleared air purification products, and solutions.Molekule recently began collaboration with key customers across th

      11/14/22 8:55:00 AM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Leadership Updates

    Live Leadership Updates

    See more
    • AeroClean Announces Appointment of Jimmy Thompson as Vice President of Strategic Sales

      Healthcare Technology Expert To Lead Targeted Sales Efforts For FDA-Cleared Germicidal UV-C Air Hygiene Technology PALM BEACH GARDENS, Fla., June 08, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company and producer of patented UV-C LED technology inside its innovative Pūrgo™ air purification device, announces Jimmy Thompson has joined the Company as Vice President of Strategic Sales. The addition of Thompson to the AeroClean team is a strategic investment to support core business and revenue growth within targeted industry verticals. Along with driving sales initiatives, Thompson will also be focused on dev

      6/8/22 8:00:00 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors

      PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the "Board"). On May 11, 2022, the Board appointed Mr. Scannell as a new director on the Board, chair of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. Mr. Scannell brings over 30 years of experienc

      5/12/22 1:00:00 PM ET
      $AERC
      $NVCR
      $PODD
      $RNLX
      Environmental Services
      Utilities
      Medical/Dental Instruments
      Health Care

    $AERC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by AeroClean Technologies Inc.

      25-NSE - Molekule Group, Inc. (0001872356) (Subject)

      11/20/23 8:46:42 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/4/23 8:47:38 PM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/3/23 3:25:23 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Financials

    Live finance-specific insights

    See more

    $AERC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $AERC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $AERC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AeroClean Technologies and Molekule to Combine in an All-Stock Merger Establishing an Industry-Leading Provider of Premium, FDA-Cleared Air Purification Products and Solutions

      Transaction Highlights Creates a pro forma company with a substantial base of revenues, a solid balance sheet and a path to profitability.A broad range of highly complementary, proprietary and patented, FDA-cleared air purification devices.Powerful brand value and recognition with an installed base of over 350,000 air purification units, providing a foundation for growing recurring revenues from both consumables and the launch of a SaaS software solution to enable facility managers to monitor and control individual room air quality on an enterprise wide basis.Expected double-digit organic revenue growth for the combined company, with gross profit expected to grow faster than revenues due to

      10/3/22 4:15:00 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/13/24 9:47:51 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/8/23 4:18:36 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/8/23 4:17:30 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Dibona Jason

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:17:27 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Tyler Ryan

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:15:43 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Khoury Amin J

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      4/20/23 7:57:21 PM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies downgraded by The Benchmark Company

      The Benchmark Company downgraded AeroClean Technologies from Buy to Hold

      6/14/22 7:14:46 AM ET
      $AERC
      Environmental Services
      Utilities
    • Benchmark initiated coverage on AeroClean Technologies

      Benchmark initiated coverage of AeroClean Technologies with a rating of Speculative Buy

      2/1/22 12:29:46 PM ET
      $AERC
      Environmental Services
      Utilities